Last reviewed · How we verify

irinotecan and ON 01910.Na

Traws Pharma, Inc. · Phase 1 active Small molecule Quality 0/100

irinotecan and ON 01910.Na is a Small molecule drug developed by Traws Pharma, Inc.. It is currently in Phase 1 development. Also known as: camptothecin-11, irinotecan HCl, Camptosar, CPT-11.

At a glance

Generic nameirinotecan and ON 01910.Na
Also known ascamptothecin-11, irinotecan HCl, Camptosar, CPT-11, diaminocyclohexane oxalatoplatinum
SponsorTraws Pharma, Inc.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about irinotecan and ON 01910.Na

What is irinotecan and ON 01910.Na?

irinotecan and ON 01910.Na is a Small molecule drug developed by Traws Pharma, Inc..

Who makes irinotecan and ON 01910.Na?

irinotecan and ON 01910.Na is developed by Traws Pharma, Inc. (see full Traws Pharma, Inc. pipeline at /company/traws-pharma-inc).

Is irinotecan and ON 01910.Na also known as anything else?

irinotecan and ON 01910.Na is also known as camptothecin-11, irinotecan HCl, Camptosar, CPT-11, diaminocyclohexane oxalatoplatinum.

What development phase is irinotecan and ON 01910.Na in?

irinotecan and ON 01910.Na is in Phase 1.

Related